1-3 of 3
Joerg Faber, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Gabriele Escherich, MD, Udo Zur Stadt, PhD, Dagmar Dilloo, MD, Joerg Faber, MD PhD, Tobias Feuchtinger, MD, Thomas Imscheiler, MD, Norbert Jorch, MD, Arnulf Pekrun, Irene Schmid, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-136149
Published: 2020
Journal Articles

Hemophagocytic Lymphohistiocytosis in Early Infancy- Pitfall of Differentiation between Hereditary and Infectious Reasons

Alexandra Russo, MD, Francesca Alt, MD, Marie Astrid Neu, MD, Stefan Eder, MD, Arthur Wingerter, MD, Khalifa El Malki, MD, Bernhard Lammle, MD, Joerg Faber, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4961.
https://doi.org/10.1182/blood-2018-99-117519
Published: 2018
Journal Articles

Global Increase in H3K79 Dimethylation in Murine and Human MLL-AF4 Lymphoblastic Leukemias.

Andrei V. Krivtsov, PhD, Zhaohui Feng, Madeleine Lemieux, Joerg Faber, MD, PhD, Xiaobo Xia, PhD, Andrew L. Kung, MD, PhD, Scott A. Armstrong, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 344.
https://doi.org/10.1182/blood.V110.11.344.344
Published: 2007